Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ali, Eslam M. H. | - |
dc.contributor.author | Abdel-Maksoud, Mohammed S. | - |
dc.contributor.author | Oh, Chang-Hyun | - |
dc.date.accessioned | 2024-01-19T20:30:14Z | - |
dc.date.available | 2024-01-19T20:30:14Z | - |
dc.date.created | 2022-01-10 | - |
dc.date.issued | 2019-04-01 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/120116 | - |
dc.description.abstract | Thienopyrimidine scaffold is a fused heterocyclic ring system that structurally can be considered as adenine, the purine base that is found in both DNA and RNA-bioisosteres. Thienopyrimidines exist in three distinct isomeric forms. The current review discusses thieno[2,3-d] pyrimidine as a one of the opulent heterocycles in drug discovery. Its broad range of medical applications such as anticancer, anti-inflammatory, anti-microbial, and CNS protective agents has inspired us to study its structure-activity relationship (SAR), along with its relevant synthetic strategies. The present review briefly summarizes synthetic approaches for the preparation of thieno[2,3-d] pyrimidine derivatives. In addition, the promising biological activities of this scaffold are also illustrated with explanatory diagrams for their SAR studies. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | RECEPTOR TYROSINE KINASE | - |
dc.subject | INITIATION-FACTOR 4E | - |
dc.subject | BIOLOGICAL EVALUATION | - |
dc.subject | DERIVATIVES BEARING | - |
dc.subject | ANTICANCER ACTIVITY | - |
dc.subject | 3-D PYRIMIDINE | - |
dc.subject | THIENO 2 | - |
dc.subject | SUBSTITUTED THIENOPYRIMIDINES | - |
dc.subject | STRUCTURAL MODIFICATIONS | - |
dc.subject | ANTIBACTERIAL AGENTS | - |
dc.title | Thieno[2,3-d] pyrimidine as a promising scaffold in medicinal chemistry: Recent advances | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmc.2019.02.044 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY, v.27, no.7, pp.1159 - 1194 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.volume | 27 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 1159 | - |
dc.citation.endPage | 1194 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000461168400002 | - |
dc.identifier.scopusid | 2-s2.0-85062071370 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Review | - |
dc.subject.keywordPlus | RECEPTOR TYROSINE KINASE | - |
dc.subject.keywordPlus | INITIATION-FACTOR 4E | - |
dc.subject.keywordPlus | BIOLOGICAL EVALUATION | - |
dc.subject.keywordPlus | DERIVATIVES BEARING | - |
dc.subject.keywordPlus | ANTICANCER ACTIVITY | - |
dc.subject.keywordPlus | 3-D PYRIMIDINE | - |
dc.subject.keywordPlus | THIENO 2 | - |
dc.subject.keywordPlus | SUBSTITUTED THIENOPYRIMIDINES | - |
dc.subject.keywordPlus | STRUCTURAL MODIFICATIONS | - |
dc.subject.keywordPlus | ANTIBACTERIAL AGENTS | - |
dc.subject.keywordAuthor | Thienopyrimidine | - |
dc.subject.keywordAuthor | Anti-inflammatory | - |
dc.subject.keywordAuthor | Anticancer | - |
dc.subject.keywordAuthor | Antimicrobial | - |
dc.subject.keywordAuthor | Antiviral | - |
dc.subject.keywordAuthor | CNS protective agents | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.